IBIO INC (IBIO) Stock News

USA - Nasdaq - NASDAQ:IBIO - US4510337086 - Common Stock

1.11 USD

+0.06 (+5.71%)

Last: 11/24/2025, 7:03:43 PM

1.115 USD

+0 (+0.45%)

After Hours: 11/24/2025, 7:03:43 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

IBIO Latest News, Press Relases and Analysis

All

Press Releases

3 hours ago - By: iBio, Inc.

iBio to Participate in the 8th Annual Evercore Healthcare Conference

6 days ago - By: Benzinga - Mentions: ENGN IMCC VREX IFRX ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 days ago - By: Zacks Investment Research - Mentions: BNGO

iBio, Inc. (IBIO) Reports Q1 Loss

12 days ago - By: iBio, Inc.

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

3 months ago - By: iBio, Inc.

iBio Announces Proposed Public Offering

a month ago - By: Benzinga - Mentions: CNC MOH BIOA MEDP ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

a month ago - By: iBio, Inc.

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

a month ago - By: iBio, Inc.

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025

3 months ago - By: iBio, Inc.

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

3 months ago - By: iBio, Inc.

iBio Announces Closing of $50 Million Public Offering

3 months ago - By: iBio, Inc.

iBio Announces Pricing of $50 Million Public Offering

5 months ago - By: iBio, Inc.

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results